一致B(200028) - 2022 Q1 - 季度财报

Financial Performance - The company achieved operating revenue of CNY 17.15 billion in Q1 2022, representing a year-on-year increase of 6.86%[6] - Net profit attributable to shareholders decreased to CNY 252.36 million, down 23.25% compared to the same period last year[6] - Basic earnings per share fell by 23.38% to CNY 0.59[6] - The company's net profit attributable to shareholders was CNY 353,150,090.07, compared to CNY 386,796,246.15 in the previous period, indicating a decrease of 8.7%[29] - The net profit for the current period is approximately 294.77 million, a decrease of 24.4% compared to 389.56 million in the previous period[32] - The total profit for the current period is approximately 376.77 million, down from 477.14 million, reflecting a decline of 21%[32] - The operating profit for the current period is approximately 375.08 million, compared to 471.34 million in the previous period, indicating a decrease of 20.4%[32] - The total comprehensive income for the current period is approximately 294.84 million, down from 389.65 million, representing a decline of 24.4%[35] - The basic and diluted earnings per share for the current period are both 0.59, compared to 0.77 in the previous period, reflecting a decrease of 23.4%[35] Revenue and Costs - Total operating revenue for the period reached CNY 17,150,856,946.54, an increase of 6.9% compared to CNY 16,049,966,325.75 in the previous period[29] - Total operating costs amounted to CNY 16,797,706,856.47, up from CNY 15,663,170,079.60, reflecting a year-over-year increase of 7.2%[29] - The distribution segment generated revenue of CNY 12.17 billion, up 7.45%, with a net profit of CNY 210 million, an increase of 10.40%[6] - The retail segment reported revenue of CNY 5.24 billion, a growth of 5.11%, but net profit dropped by 63.80% to CNY 32 million[6] - Revenue from sales of goods and services received cash of approximately 16.76 billion, an increase from 15.19 billion in the previous period, reflecting a growth of 10.2%[36] Assets and Liabilities - The total assets at the end of the reporting period were CNY 44.84 billion, an increase of 4.82% from the end of the previous year[4] - Total assets increased to CNY 44,844,103,338.63, compared to CNY 42,783,682,431.81, reflecting a growth of 4.8%[28] - Total liabilities rose to CNY 26,527,298,299.24 from CNY 24,761,469,733.31, an increase of 7.1%[25] - Accounts receivable increased to CNY 18,445,260,411.58 from CNY 15,964,603,345.91, representing a growth of 9.2%[22] - Inventory levels rose to CNY 8,058,564,605.96, up from CNY 7,621,541,595.08, marking an increase of 5.8%[22] Cash Flow - Cash flow from operating activities improved by 29.11%, with a net outflow of CNY 217.45 million[6] - Cash received from operating activities decreased by CNY 64.19 million, a decline rate of -30.61%, primarily due to a decrease in special epidemic reserve funds and deposits received[10] - Cash flow from investment activities decreased by CNY 6.84 million, a decline rate of -98.78%, mainly due to the absence of investment project exit payments this period[10] - Cash flow from financing activities decreased by CNY 276.52 million, a decline rate of -71.17%, primarily due to reduced factoring business recoveries and increased rental payments[10] - Cash and cash equivalents net increase decreased by CNY 126.20 million, a decline rate of -171.70%, mainly due to reduced factoring business recoveries[10] - Total cash and cash equivalents at the end of the period amounted to CNY 4.87 billion, down from CNY 5.13 billion at the beginning of the year[19] - The company reported a cash inflow from financing activities of approximately 112.01 million, compared to 388.52 million in the previous period, indicating a decrease of 71.1%[39] - Cash and cash equivalents at the end of the period amount to approximately 4.53 billion, down from 5.33 billion in the previous period[42] Investments and Subsidies - Investment income decreased by 74.30% due to the poor performance of joint ventures[8] - The company received government subsidies totaling CNY 15.56 million during the reporting period[7] - The company reported a cash and cash equivalents balance of CNY 1,500,000,000, which is a strategic reserve for future investments[27] Operational Challenges - The weighted average return on equity decreased by 0.65 percentage points to 1.68%[6] - Accounts receivable turnover days increased due to delayed medical insurance allocations, leading to a corresponding increase in bad debt provisions[10] - Asset impairment losses decreased by CNY 1.83 million, a decline rate of -52.58%, primarily due to a reduction in inventory write-down provisions[10] - Asset disposal gains increased by CNY 0.71 million, a growth rate of 259.86%, mainly from the disposal of right-of-use assets from retail store lease terminations[10] - Operating income decreased by CNY 4.08 million, a decline rate of -64.08%, due to a reduction in the write-off of payable items[10] - The company incurred a credit impairment loss of approximately 25.90 million, compared to 17.20 million in the previous period, indicating an increase of 50.5%[32] Future Outlook - The company plans to expand its market presence through new product launches and strategic partnerships in the upcoming quarters[27] - Research and development expenses for the period were CNY 264,532,679.98, up from CNY 237,615,927.36, indicating a focus on innovation and product development[29]